Description: This paper explores how health care complexity challenges us to expand our repertoire of actuarial methods—and even recast our trend driver paradigm—in order to do our jobs better and maintain our credibility.

Description: Letter from the Editor Greetings to All Health Actuaries! by Jeffrey D. Miller from Health Section News, April 2001, Issue No. 40.

Description: Adding value in the development, production and marketing process of medical devises regulatory environment, designer/manufacturer perspective, product failure and litigation risk. Issue No. 44.

Description: The article offers a more nuanced approach to caregiving as the population ages, suggesting our current focus on planning leaves out most people. Instead find solutions for non-planners!

Description: This is a case study on group health from the spring 2012 exam of the Society of Actuaries.

Description: Society of Actuaries Research Brief Impact of COVID-19, May 15, 2020

Description: Summary in Simplified Chinese

Description: This report provides highlights of a weekly survey of practices regarding the mitigation of the spread of COVID-19 in the U.S. during the week of November 28, 2020. The survey asks about the degree to which the respondents perceive that people in their community are following 21 common mitigation practices. The responses are separated by state and compared to state level statistics regarding the level of COVID-19 infections from the Johns Hopkins COVID database for the same time period.

Description: The Health Care Cost Institute (HCCI) recently released their annual health care cost and utilization report on February 13, 2020. This report illustrates employer group commercial health care costs and trends from 2014 – 2018.

Description: Chronic Kidney Disease (CKD) affects many lives and has a large impact on health systems around the world. To better understand and predict costs for insurance plan members with CKD in the United States, we built a new model of their individual costs. Our model is the first to explicitly model both the CKD stage transition process and the distribution of costs given those stages.